151 related articles for article (PubMed ID: 11441014)
21. Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling.
Wess J; Blin N; Mutschler E; Blüml K
Life Sci; 1995; 56(11-12):915-22. PubMed ID: 10188793
[TBL] [Abstract][Full Text] [Related]
22. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
Vogel WK; Sheehan DM; Schimerlik MI
Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
[TBL] [Abstract][Full Text] [Related]
23. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Brichta L; Bloodworth LM; Li JH; Wess J
J Biol Chem; 2005 Jul; 280(26):24870-9. PubMed ID: 15870064
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis.
Liu J; Blin N; Conklin BR; Wess J
J Biol Chem; 1996 Mar; 271(11):6172-8. PubMed ID: 8626406
[TBL] [Abstract][Full Text] [Related]
25. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor.
Urizar E; Claeysen S; Deupí X; Govaerts C; Costagliola S; Vassart G; Pardo L
J Biol Chem; 2005 Apr; 280(17):17135-41. PubMed ID: 15722344
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of transmembrane domain 2 of the M1 muscarinic acetylcholine receptor.
Bee MS; Hulme EC
J Biol Chem; 2007 Nov; 282(44):32471-9. PubMed ID: 17823120
[TBL] [Abstract][Full Text] [Related]
28. Dissecting the conserved NPxxY motif of the M3 muscarinic acetylcholine receptor: critical role of Asp-7.49 for receptor signaling and multiprotein complex formation.
Borroto-Escuela DO; Romero-Fernandez W; García-Negredo G; Correia PA; Garriga P; Fuxe K; Ciruela F
Cell Physiol Biochem; 2011; 28(5):1009-22. PubMed ID: 22178951
[TBL] [Abstract][Full Text] [Related]
29. Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding.
Wess J; Gdula D; Brann MR
EMBO J; 1991 Dec; 10(12):3729-34. PubMed ID: 1657592
[TBL] [Abstract][Full Text] [Related]
30. The allosteric site regulates the voltage sensitivity of muscarinic receptors.
Hoppe A; Marti-Solano M; Drabek M; Bünemann M; Kolb P; Rinne A
Cell Signal; 2018 Jan; 42():114-126. PubMed ID: 29056499
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
[TBL] [Abstract][Full Text] [Related]
32. Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
Messer WS; Rajeswaran WG; Cao Y; Zhang HJ; el-Assadi AA; Dockery C; Liske J; O'Brien J; Williams FE; Huang XP; Wroblewski ME; Nagy PI; Peseckis SM
Pharm Acta Helv; 2000 Mar; 74(2-3):135-40. PubMed ID: 10812950
[TBL] [Abstract][Full Text] [Related]
33. Identification of a ligand-dependent switch within a muscarinic receptor.
Spalding TA; Burstein ES; Henderson SC; Ducote KR; Brann MR
J Biol Chem; 1998 Aug; 273(34):21563-8. PubMed ID: 9705286
[TBL] [Abstract][Full Text] [Related]
34. The role of charge interactions in muscarinic agonist binding, and receptor-response coupling.
Hulme EC; Curtis CA; Page KM; Jones PG
Life Sci; 1995; 56(11-12):891-8. PubMed ID: 10188790
[TBL] [Abstract][Full Text] [Related]
35. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
Matsui H; Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic classification of mutants: a tool for understanding ligand binding and activation of muscarinic acetylcholine receptors.
Hulme EC; Bee MS; Goodwin JA
Biochem Soc Trans; 2007 Aug; 35(Pt 4):742-5. PubMed ID: 17635138
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.
Kukkonen A; Peräkylä M; Akerman KE; Näsman J
J Biol Chem; 2004 Dec; 279(49):50923-9. PubMed ID: 15452105
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
Boucard AA; Roy M; Beaulieu ME; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2003 Sep; 278(38):36628-36. PubMed ID: 12842881
[TBL] [Abstract][Full Text] [Related]
39. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
Huang XP; Williams FE; Peseckis SM; Messer WS
Mol Pharmacol; 1999 Oct; 56(4):775-83. PubMed ID: 10496961
[TBL] [Abstract][Full Text] [Related]
40. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
Maggio R; Vogel Z; Wess J
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3103-7. PubMed ID: 8385357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
